CureApp
Healthcare Software · Japan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Nihonbashi Kodenmacho Ys Building 12-5 4...Phone Number
+61 354221178Website
www.cureapp.co.jpRevenue
$14.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About CureApp
CureApp is dedicated to revolutionizing treatment through software by leveraging evolving technology to address societal challenges in healthcare. The company develops evidence-based medical device programs and therapeutic applications aimed at improving treatment outcomes for conditions inadequately addressed by traditional pharmaceuticals and hardware. Their services include mobile health programs for corporations, promoting health management and wellness in the workplace. CureApp's innovative digital therapies aim to provide personalized interventions and support for patients, enhancing their treatment experience beyond conventional medical settings.Explore more
CureApp Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CureApp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CureApp has new funding data
CureApp, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CureApp recently announced quarterly report
Product Launch: Get notified when CureApp launches new products
Click to see if CureApp had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CureApp
Check out if CureApp is spiking on competitors!
Check if CureApp has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined CureApp as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
CureApp is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
CureApp is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about CureApp.
CureApp financials insights
Gather financial insights about CureApp, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series G
$44.7M
CureApp Tech Stack
A closer look at the technologies used by CureApp
See more technologies
CureApp News & Media
Carlyle to acquire significant minority stake in CureApp for JPY7bn
Carlyle to acquire significant minority stake in CureApp for JPY7bn Submitted 16/08/2022 - 10:23am Carlyle is to acquire a significant minority stake in CureApp, Inc, a Japanese medical technology (medtech) company and prescription digital therapeutics provider, for JPY7 billion as part of CureApp’s Series G funding. Carlyle's investment brings the total amount of capital raised by CureApp to approximately JPY13.4 billion. Carlyle will have one board seat as part of the transaction. Founded in 2Carlyle to Acquire a Significant Minority Stake in CureApp, a Leading Prescription Digital ...
Strategic growth investment in CureApp to support the rollout of its hypertension app and advance its new development pipeline, as digital therapeutics gain traction in JapanFive Japanese Startup Companies to be Featured in Innovation Showcase of 2022 Japan – U.S. Innovation Awards Program
SAN FRANCISCO, CA, USA, June 22, 2022 /EINPresswire.com/ -- The Japan – U.S. Innovation Awards Program (https://www.usjinnovate.org) is proud to announce five exciting Japanese startup companies that will be featured in the Innovation Showcase of the …Japan clears CureApp's DTx app for hypertension | MobiHealthNews
The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CureApp
Sign Up For FreeTo access detailed company insights
CureApp is dedicated to revolutionizing treatment through software by leveraging evolving technology to address societal challenges in healthcare. The company develops evidence-based medical device programs and therapeutic applications aimed at improving treatment outcomes for conditions inadequately addressed by traditional pharmaceuticals and har... Read More
